Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yvon E et al. – Redirecting human T lymphocytes to the tumor–associated ganglioside GD2 generates effector cells with antimelanoma activity that should be testable in subjects with disease.

Today in Dermatologic Oncology...keeping you current

Phase II trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases
Clinical Cancer Research, 12/10/09

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Proceedings of the National Academy of Sciences of the United States of America, 12/10/09

Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis
Cancer Research, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address